BabyMD (Hoola Health) raises $5M Series A led by Peak XV's Surge
What's the deal? Hoola Health, a Bengaluru-based paediatric healthcare startup formerly known as BabyMDDealroom has a profile for this one. Try Dealroom →, has raised $5 million in a round led by Peak XV's Surge. W Health VenturesDealroom has a profile for this one. Try Dealroom → and angel investors including Ashish GuptaDealroom has a profile for this one. Try Dealroom →, Abhishek GoyalDealroom has a profile for this one. Try Dealroom →, and Bijou KurienDealroom has a profile for this one. Try Dealroom → also participated.
Founded in 2024 by Deeksha Senguttuvan, Hoola Health runs child-focused clinics that combine in-person care — consultations, vaccinations, diagnostics, developmental therapies, and specialist visits — with digital tools for growth tracking, prescriptions, and vaccination records.
The startup plans to use the capital to expand into new markets, strengthen its technology, and scale its integrated care model.
Why now? Hoola Health has hit early traction milestones that make a growth-stage raise logical. It operates five clinics and has served more than 20,000 families in 18 months. Over 60% of new patients come through word-of-mouth referrals, and more than 60% of monthly visits are from returning families.
Nearly 35% of its revenue comes from developmental therapies, signalling strong demand for integrated child healthcare beyond basic consultations. The rebrand from BabyMD to Hoola Health coincides with the round, positioning the company for a broader range of services and age groups.
What could go wrong? Scaling a clinic-based model is capital-intensive and operationally complex. Hoola Health plans to open 30 new clinics across Bengaluru, Hyderabad, and Delhi NCR over the next two years — a sixfold increase from its current footprint. Maintaining quality and the word-of-mouth engine that drives patient acquisition will get harder as it enters new cities.
Adding new verticals like paediatric dental care stretches the model further, raising the risk of losing focus.
The signal: Hoola Health's investor mix — a healthcare-specialist fund in W Health Ventures alongside Peak XV's Surge programme and seasoned angel investors such as Ashish Gupta — points to conviction that India's fragmented paediatric care market is ready for a branded, multi-service chain. The fact that developmental therapies already account for 35% of revenue suggests the startup has found a higher-margin wedge that most standalone paediatricians don't offer, giving it a differentiation lever as it attempts a rapid, multi-city rollout.
Read more: m.dailyhunt.in
